Nanoparticle Delivery at "Cellular Level" to Advance Nanomedicine
An analytical method that helped study the distribution of nanoparticle delivery systems at the cellular level was developed to advance nanomedicine.
Stay updated with breaking news from Nanoparticle Delivery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An analytical method that helped study the distribution of nanoparticle delivery systems at the cellular level was developed to advance nanomedicine.
To advance nanomedicine, researchers will need to overcome the barrier that prevents clinical applications of nanomaterial systems.
Preclinical data show potential for use of Genprex's Oncoprex nanoparticle delivery system in treating colon cancer.
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting News provided by Share this article Share this article SAN DIEGO, April 27, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced three data presentations to be delivered at the upcoming American Society of Gene and Cell Therapy (ASGCT) 24th Annual Meeting, being held virtually May 11-14, 2021. Poseida ...